<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04588740</url>
  </required_header>
  <id_info>
    <org_study_id>21983</org_study_id>
    <nct_id>NCT04588740</nct_id>
  </id_info>
  <brief_title>Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency</brief_title>
  <official_title>Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary inorganic nitrate, in the form of beet root juice, is a nutritional intervention,&#xD;
      considered to be an exercise enhancer due to its capacity to increase Nitric Oxide (NO)&#xD;
      bioavailability. Increasing NO bioavailability has been associated with improved&#xD;
      mitochondrial respiration, muscle tissue perfusion and contractile function which may lead to&#xD;
      improved exercise capacity. However, the majority of the literature is on male subjects. This&#xD;
      limits the applicability of this supplement in females. Therefore, our project aims to&#xD;
      determine sex-differences and the specific sex-response across the menstrual cycle of dietary&#xD;
      nitrate supplementation on exercise efficiency, strength and fatigue resistance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dietary inorganic nitrate is a nutritional intervention, considered to be an exercise&#xD;
      enhancer due to its capacity to increase Nitric Oxide (NO) bioavailability. Increasing NO&#xD;
      bioavailability has been associated with improved mitochondrial respiration, muscle tissue&#xD;
      perfusion and contractile function which may lead to improved exercise capacity. The amount&#xD;
      of research investigating the effects of beet root juice supplementation (which contains a&#xD;
      high concentration of inorganic nitrate) on exercise responses has increased dramatically in&#xD;
      the last 10 years-with over 150 studies in the literature. To date there are only 7 studies&#xD;
      looking at exercise responses following inorganic nitrate supplementation specifically in&#xD;
      females. Given the physiological differences between males and females studies looking into&#xD;
      sex-differences and the specific sex-response are warranted.&#xD;
&#xD;
      The purpose of this study is to investigate whether dietary nitrate supplementation has&#xD;
      different effects on muscle contractile function in males and females. We will assess muscle&#xD;
      function during an isokinetic protocol where subjects will have to produce maximum efforts at&#xD;
      three different torque development speeds (i.e. 180, 270 and 360). This will be followed with&#xD;
      a fatigue protocol which will consist of intermittent voluntary contractions at 60% of their&#xD;
      maximal voluntary contraction until exhaustion provided by research in the Sport Medicine -&#xD;
      Kinesiology department. Thus, we will be able to distinguish the effect of dietary nitrate on&#xD;
      contractile function and its capacity to delay fatigue in a sex-specific manner.&#xD;
&#xD;
      The hypothesis of this study is that there will be a group difference between males and&#xD;
      females for change in peak power and time to exhaustion after consuming dietary nitrate (in&#xD;
      the form of concentrated beetroot juice) for 5 days.&#xD;
&#xD;
      In order to test this hypothesis, we will recruit 24 healthy recreationally active&#xD;
      individuals (12 females + 12 males) in a randomized, double-blind, placebo controlled, cross&#xD;
      over design.&#xD;
&#xD;
      Specific Aim 1: Determine the sex-differences of the effect of dietary nitrate&#xD;
      supplementation on peak power. We hypothesize that the males will have larger improvement in&#xD;
      peak power following dietary nitrate.&#xD;
&#xD;
      Specific Aim 2: Determine the sex-differences of the effect of dietary nitrate on fatigue&#xD;
      during an intermittent isometric fatigue protocol. We hypothesize that the females will have&#xD;
      a greater improvement in fatigue resistance than males.&#xD;
&#xD;
      Specific Aim 3: Determine the sex-differences of the effect of dietary nitrate on oxygen&#xD;
      consumption during sub maximal exercise.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This is a randomized, double-blind, placebo-controlled, cross-over design. This means that all subjects will complete both supplementation phases in a randomized order.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle function - Maximal knee extensor speed and power determined using isokinetic dynamometry</measure>
    <time_frame>Male subjects (2 occasions)- It will be measured on day 5 of supplementation (placebo or nitrate). Female subjects (4 times) - It will be measured between days 3-5 and 10-15 of their menstrual cycle in two different cycles.</time_frame>
    <description>This is an isokinetic (same speed over range of motion) strength test that will measure peak torque of the quadricep and hamstring (Nm/kg) and average power (W/kg). The testing protocol will be completed at three different speeds 180degrees/second, 270degrees/second and 360degrees/second.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen consumption during a submaximal exercise</measure>
    <time_frame>Male subjects (2 occasions)- It will be measured on day 5 of supplementation (placebo or nitrate). Female subjects (4 times) - It will be measured between days 3-5 and 10-15 of their menstrual cycle in two different cycles.</time_frame>
    <description>Treatment differences (BR v PL) and sex differences (females vs males) in exercise economy (i.e. oxygen consumption) during a submaximal exercise bout (i.e. 75% Gas exchange threshold).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to exhaustion during a high intensity exercise bout on a cycle ergometer</measure>
    <time_frame>Male subjects (2 occasions)- It will be measured on day 5 of supplementation (placebo or nitrate). Female subjects (4 times) - It will be measured between days 3-5 and 10-15 of their menstrual cycle in two different cycles.</time_frame>
    <description>Treatment differences (BR v PL) and sex differences (females vs males) in exercise capacity during a constant work rate (i.e. 70% delta) tested on a cycle ergometer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Dietary nitrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The active treatment, beetroot juice (BEET IT, James White Drinks, Ipswich, UK), contains 6.2mmol of inorganic nitrate. Participants will continue supplementation until they complete all testing visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo beet root juice is made by the same company (BEET IT, James White Drinks, Ipswich, UK) and contains no inorganic nitrate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>concentrated beet root juice</intervention_name>
    <description>On average, we will expect subjects to ingest the supplement for approximately 5 days minimum depending on their testing schedule. On each testing day subjects will be asked to consume the two bottles of either beetroot juice (BRJ) or Placebo 2.5 hours before testing time. Specifically, for female subjects, they will be asked to start their supplementation on day 1 of menses. On day 3-4 they will take the last 2 shots. Female subjects' wash-out period will go according to their menstrual cycle as we will be controlling for hormone fluctuation (low vs high estrogen phase) know to interact with nitric oxide physiology.</description>
    <arm_group_label>Dietary nitrate</arm_group_label>
    <other_name>dietary inorganic nitrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo beet root juice</intervention_name>
    <description>This will follow the same supplementation regime as explained above but this supplement taste and looks exactly the same as the nitrate-rich beet root juice. It is provided by the same company that produces the concentrated beet root juice shots (Beet It, UK)</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female participants in good general health as assessed by the standard&#xD;
             procedures described below and specifically meeting normal blood pressure range&#xD;
             (systolic: 120-129, diastolic: 80-84) and normal BMI range (18.5-24.9)&#xD;
&#xD;
               -  Engaged in physical activity and/or recreational sport but not highly-trained, as&#xD;
                  assessed by the investigator in personal consultation and laboratory stress test.&#xD;
&#xD;
               -  No orthopedic limitations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Known pulmonary, cardiovascular or metabolic disease&#xD;
&#xD;
               -  Food allergies including phenylketonurea (PKU)&#xD;
&#xD;
               -  Regular use of dietary supplements within 6 months prior to the start of the&#xD;
                  study&#xD;
&#xD;
               -  Taking any dietary/sport supplements that could affect nitrate metabolism: Sport&#xD;
                  supplements containing the amino acids L-arginine, L-citrulline, beta-alanine,&#xD;
                  Creatine, Nitrate based pre-work out supplements&#xD;
&#xD;
               -  Blood donation within 3 months prior to the start of the study&#xD;
&#xD;
               -  Substance abuse within 2 years of the start of the study&#xD;
&#xD;
               -  Smokers&#xD;
&#xD;
               -  Hyper- or hypotension medication&#xD;
&#xD;
               -  Pregnant or lactating&#xD;
&#xD;
               -  Not having a regular menstrual cycle (minimum of 10-12 menses per year)&#xD;
&#xD;
               -  Stopped using a contraceptive method or started a new contraceptive method within&#xD;
                  3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason D. Allen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason D. Allen, PhD</last_name>
    <phone>434-243-0736</phone>
    <email>ja6af@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason D. Allen, PhD</last_name>
      <phone>434-243-0736</phone>
      <email>ja6af@virginia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 14, 2020</last_update_submitted>
  <last_update_submitted_qc>October 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Jason Allen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>beet root juice</keyword>
  <keyword>dietary nitrate</keyword>
  <keyword>nitric oxide</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this RCT, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

